Skip to search.
 FTSE 100 Down 1.25%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
361.38 Down 9.94(2.68%) 16:31 - Nasdaq Real Time Price
Prev Close:371.32
Open:370.06
Bid:361.67 x 100
Ask:362.34 x 400
1y Target Est:475.95
Beta:1.55676
Next Earnings Date: 5-May-16REGN Earnings announcement
Day's Range:360.27 - 371.09
52wk Range:348.96 - 605.93
Volume:346,724
Avg Vol (3m):955,855
Market Cap:37.78b
P/E (ttm):65.47
EPS (ttm):5.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 2.68%37.78b
AMGNDown 1.59%115.56b

Key Statistics

Forward P/E (1 yr):22.25
P/S (ttm):9.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :11.47
Quarterly EPS Est (Mar-16) :2.58
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.57

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback